Macular Abnormalities in Vogt-Koyanagi-Harada Disease

Ocul Immunol Inflamm. 2019;27(8):1195-1202. doi: 10.1080/09273948.2019.1624781. Epub 2019 Aug 15.

Abstract

Purpose: To investigate the prevalence of macular abnormalities in Chinese Vogt-Koyanagi-Harada (VKH) patients.Methods: Clinical characteristics, therapeutic effectiveness and visual outcome were reviewed and analyzed.Results: The most common macular abnormality was macular edema (ME), followed by macular choroidal neovascularization (CNV). Macular abnormalities were associated with recurrent episodes, disease course and visual acuity ≤20/50 at first visit. The prevalence of macular abnormalities in patients who were not treated according to our regular treatment regimen with corticosteroids combined with immunosuppressive agents and who were followed-up for at least one year (13.1%) was significantly higher than in patients receiving the regular treatment (5.7%). Visual improvement was found in 66.7% of eyes with macular abnormalities after regular treatment.Conclusion: Macular abnormalities were associated with recurrent uveitis, course of disease and lower visual acuity at first visit. Regular treatment could prevent the development of macular abnormalities and improved visual outcome in most patients.

Keywords: VKH disease; macular abnormalities; macular choroidal neovascularization; macular edema.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / etiology
  • Disease Progression
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Macula Lutea / pathology*
  • Macular Edema / diagnosis*
  • Macular Edema / etiology
  • Male
  • Middle Aged
  • Prognosis
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Uveomeningoencephalitic Syndrome / complications
  • Uveomeningoencephalitic Syndrome / drug therapy
  • Uveomeningoencephalitic Syndrome / pathology*
  • Young Adult

Substances

  • Glucocorticoids
  • Immunosuppressive Agents